30 March 2024>: Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer
Han Fei Wang 12CDEF , Ying Chen 12G , Bang Cao 3E , Jing Pei 12A*DOI: 10.12659/MSM.943049
Med Sci Monit 2024; 30:e943049
Table 2 Comparison of HSP90α value between patients with TNBC and healthy controls.
Groups | HSP90α (mean±SD) | HSP90α <81.09 | HSP90α ≥81.09 | Number |
---|---|---|---|---|
Healthy controls | 67.16±33.15 | 110 (86.61%) | 17 (13.39%) | 127 |
TNBC patients | 107.94±23.20 | 76 (59.38%) | 52 (40.62%) | 127 |